160 related articles for article (PubMed ID: 8765433)
1. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs.
Andersson BS; Sadeghi T; Siciliano MJ; Legerski R; Murray D
Cancer Chemother Pharmacol; 1996; 38(5):406-16. PubMed ID: 8765433
[TBL] [Abstract][Full Text] [Related]
2. Constancy of the relative biological effectiveness of 42 MeV (p-->Be+) neutrons among cell lines with different DNA repair proficiencies.
Britten RA; Murray D
Radiat Res; 1997 Oct; 148(4):308-16. PubMed ID: 9339946
[TBL] [Abstract][Full Text] [Related]
3. The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway.
Murray D; Rosenberg E
Mutat Res; 1996 Dec; 364(3):217-26. PubMed ID: 8960133
[TBL] [Abstract][Full Text] [Related]
4. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
Andersson BS; Mroue M; Britten RA; Murray D
Cancer Res; 1994 Oct; 54(20):5394-400. PubMed ID: 7923171
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide.
Murray D; Vallee-Lucic L; Rosenberg E; Andersson B
Anticancer Res; 2002; 22(1A):21-6. PubMed ID: 12017289
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
Damia G; Imperatori L; Stefanini M; D'Incalci M
Int J Cancer; 1996 Jun; 66(6):779-83. PubMed ID: 8647649
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of arsenite metabolites in wild type CHO cells and in cells deficient in excision repair cross-complementing 1 and 2.
Vahidnia A; Pablo RF; van der Voet GB; van der Straaten RJ; de Wolff FA
Toxicol In Vitro; 2008 Sep; 22(6):1662-5. PubMed ID: 18602460
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide excision repair impairment by nodularin in CHO cell lines due to ERCC1/XPF inactivation.
Lankoff A; Sochacki J; Spoof L; Meriluoto J; Wojcik A; Wegierek A; Verschaeve L
Toxicol Lett; 2008 Jun; 179(2):101-7. PubMed ID: 18514445
[TBL] [Abstract][Full Text] [Related]
9. DNA repair mechanisms are involved in the hypoxia-dependent toxicity of NLCQ-1 (NSC 709257) and its synergistic interaction with alkylating agents.
Papadopoulou MV; Bloomer WD
In Vivo; 2007; 21(2):175-80. PubMed ID: 17436565
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3.
Lee KB; Parker RJ; Bohr V; Cornelison T; Reed E
Carcinogenesis; 1993 Oct; 14(10):2177-80. PubMed ID: 8222071
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cyclophosphamide resistance in a human myeloid leukemia cell line.
Andersson BS; Mroue M; Britten RA; Farquhar D; Murray D
Acta Oncol; 1995; 34(2):247-51. PubMed ID: 7718264
[TBL] [Abstract][Full Text] [Related]
12. ERCC1/ERCC4 5'-endonuclease activity as a determinant of hypoxic cell radiosensitivity.
Murray D; Macann A; Hanson J; Rosenberg E
Int J Radiat Biol; 1996 Mar; 69(3):319-27. PubMed ID: 8613681
[TBL] [Abstract][Full Text] [Related]
13. Characterization of illudin S sensitivity in DNA repair-deficient Chinese hamster cells. Unusually high sensitivity of ERCC2 and ERCC3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agents.
Kelner MJ; McMorris TC; Estes L; Rutherford M; Montoya M; Goldstein J; Samson K; Starr R; Taetle R
Biochem Pharmacol; 1994 Jul; 48(2):403-9. PubMed ID: 8053936
[TBL] [Abstract][Full Text] [Related]
14. High-dose selection with mafosfamide results in sensitivity to DNA cross-linking agents: characterization of hypersensitive cell lines.
Fritz G; Hengstler JG; Kaina B
Cancer Res; 1997 Feb; 57(3):454-60. PubMed ID: 9012473
[TBL] [Abstract][Full Text] [Related]
15. Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.
van Huis-Tanja LH; Kweekel DM; Lu X; Franken K; Koopman M; Gelderblom H; Antonini NF; Punt CJ; Guchelaar HJ; van der Straaten T
Mutat Res; 2014 Jan; 759():37-44. PubMed ID: 24220697
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity in nucleotide excision repair mutants of rodent complementation groups 1 and 4.
Busch DB; van Vuuren H; de Wit J; Collins A; Zdzienicka MZ; Mitchell DL; Brookman KW; Stefanini M; Riboni R; Thompson LH; Albert RB; van Gool AJ; Hoeijmakers J
Mutat Res; 1997 Mar; 383(2):91-106. PubMed ID: 9088342
[TBL] [Abstract][Full Text] [Related]
17. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability.
Takanami T; Nakamura J; Kubota Y; Horiuchi S
Mutat Res; 2005 Apr; 582(1-2):135-45. PubMed ID: 15781218
[TBL] [Abstract][Full Text] [Related]
18. Expression of human O6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents.
Wu ZN; Chan CL; Eastman A; Bresnick E
Cancer Res; 1992 Jan; 52(1):32-5. PubMed ID: 1727384
[TBL] [Abstract][Full Text] [Related]
19. Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity.
Cai Y; Wu MH; Ludeman SM; Grdina DJ; Dolan ME
Cancer Res; 1999 Jul; 59(13):3059-63. PubMed ID: 10397244
[TBL] [Abstract][Full Text] [Related]
20. Involvement of nucleotide excision repair (NER) system in repair of mono ADP-ribosylated dG adducts produced by pierisin-1, a cytotoxic protein from cabbage butterfly.
Shiotani B; Watanabe M; Totsuka Y; Sugimura T; Wakabayashi K
Mutat Res; 2005 May; 572(1-2):150-5. PubMed ID: 15790498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
